Last reviewed · How we verify
NCT04706442
Effectiveness of 'Supportive Parenting App' on Parental and Newborn Outcomes
NA trial testing Supportive Parenting Application in Postnatal Depression in 398 participants. Completed in 22 March 2022.
22 March 2022
Quick facts
| Lead sponsor | National University of Singapore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 398 |
| Start date | 1 March 2020 |
| Primary completion | 22 March 2022 |
| Estimated completion | 22 March 2022 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Supportive Parenting Application
Conditions studied
- Postnatal Depression — all drugs for Postnatal Depression →
- Self Efficacy — all drugs for Self Efficacy →
- Parent-Child Relations — all drugs for Parent-Child Relations →
- Development, Child — all drugs for Development, Child →
Sponsor
National University of Singapore
Who can join
Adults 21 to 65, any sex, with Postnatal Depression or Self Efficacy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Supportive Parenting App is a theory-based perinatal educational intervention for couples administered through a mobile application. The intervention comprise of knowledge-based content, informational videos and audio, discussion forum, peer volunteer chat group, and a frequently asked questions (FAQ) expert advice section. The aims of the study are to: 1. develop theory-based supportive parenting App (SPA) intervention for both first-time and experienced parents across perinatal period 2. examine its effectiveness on parental outcomes: including maternal depression at 12 months postpartum (primary outcome), paternal depression, parental anxiety, parenting self-efficacy, help - seeking behavior (social support), parental bonding and parenting satisfaction (secondary outcomes); and new-born outcomes: physical, social and emotional developments (secondary outcomes) 3. evaluate SPA's cost-effectiveness as compared to standard perinatal care across major restructured hospitals, and 4. examine the perceptions of parents in receiving this intervention. When compared with those in the control group receiving standard care: 1. parents receiving SPA intervention will have better- emotional well-being (reduced depression and anxiety);parenting self-efficacy; social support; bonding and satisfaction. 2. new-borns of parents receiving SPA will have better physical, social and emotional development 3. It will be more cost-effective to provide SPA than the standard care
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluating the Effectiveness of the Supportive Parenting App on Parental Outcomes: Randomized Controlled Trial.
Shorey S, Law E, Thilagamangai, Mathews J, et al · · 2023 · cited 31× · PMID 36645699 · DOI 10.2196/41859 -
Evaluating the Effects of the Supportive Parenting App on Infant Developmental Outcomes: Longitudinal Study.
Shorey S, Chong YS, Shi L, Chua JS, et al · · 2023 · cited 1× · PMID 36811952 · DOI 10.2196/43885
Verify or expand the search:
- PubMed search for NCT04706442
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postnatal Depression
Currently open trials in the same condition.
- NCT06871397 — Effectiveness of an Online Biopsychosocial Intervention to Improve Well-being and Mental Health During Pregnancy · NA · recruiting
- NCT07017621 — Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of th · recruiting
Other National University of Singapore trials
Trials by the same sponsor.
- NCT07519642 — Frailty Improvement Through Technology With Informal Caregiver Supported Exercise (FITWISE) for Pre-frail and Frail Comm · NA · not yet recruiting
- NCT07525492 — Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial · NA · not yet recruiting
- NCT07375459 — Community-based Mobile-assisted Brief Intervention for Smoking Cessation · NA · recruiting
- NCT07444073 — Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock · not yet recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04706442 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National University of Singapore
- Last refreshed: 12 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04706442.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing